These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19011200)

  • 1. Hepatocellular carcinoma: progression in patients with hepatitis B versus C virus infection.
    Yu JS; Kim KW
    Radiology; 2008 Dec; 249(3):1082; author reply 1082-3. PubMed ID: 19011200
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between chronic viral hepatitis and hepatocellular carcinoma].
    Karev VE; Tsinzerling VA; Komarova DV; Iakovlev AA
    Vopr Onkol; 2000; 46(4):427-32. PubMed ID: 11147418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?
    Warner N; Locarnini S
    Antivir Ther; 2009; 14(2):139-42. PubMed ID: 19430088
    [No Abstract]   [Full Text] [Related]  

  • 4. [The prophylaxis of hepatocellular carcinoma by interferon-alpha in virus-induced cirrhosis].
    Merle P; Zoulim F; Vitvitski L; Trépo C
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1166-76. PubMed ID: 11173729
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocellular carcinoma arising from hepatocellular adenoma in a hepatitis B virus-associated cirrhotic liver.
    Seo JM; Lee SJ; Kim SH; Park CK; Ha SY
    Clin Radiol; 2012 Apr; 67(4):329-33. PubMed ID: 22079485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis B and C virus markers in hepatocellular carcinoma].
    Tanikawa K
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):687-92. PubMed ID: 12442468
    [No Abstract]   [Full Text] [Related]  

  • 7. [From viral hepatitis to hepatocellular carcinoma].
    Okita K
    Nihon Naika Gakkai Zasshi; 2001 Mar; 90(3):452-6. PubMed ID: 11307535
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatocellular carcinoma and coinfection with hepatitis B and C. Making a difficult situation worse.
    Kurtz RC
    Cancer; 1999 Sep; 86(5):741-3. PubMed ID: 10463966
    [No Abstract]   [Full Text] [Related]  

  • 9. [The natural course of hepatitis B and hepatitis C virus infection].
    Schwabe RF; Stremmel W
    Praxis (Bern 1994); 1998 Oct; 87(42):1403-7. PubMed ID: 9824947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma (HCC): a global perspective.
    Ferenci P; Fried M; Labrecque D; Bruix J; Sherman M; Omata M; Heathcote J; Piratsivuth T; Kew M; Otegbayo JA; Zheng SS; Sarin S; Hamid SS; Modawi SB; Fleig W; Fedail S; Thomson A; Khan A; Malfertheiner P; Lau G; Carillo FJ; Krabshuis J; Le Mair A;
    J Clin Gastroenterol; 2010 Apr; 44(4):239-45. PubMed ID: 20216082
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of hepatitis B and hepatitis C virus coinfection in chronic liver disease.
    Xess A; Kumar M; Minz S; Sharma HP; Shahi SK
    Indian J Pathol Microbiol; 2001 Jul; 44(3):253-5. PubMed ID: 12024907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
    Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: New and emerging risks.
    Sherman M
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S215-22. PubMed ID: 20547306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of hepatocellular carcinoma in chronic viral B and viral C liver diseases.
    Acalovschi M
    Rom J Gastroenterol; 2003 Jun; 12(2):123-30. PubMed ID: 12853999
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic approach to chronic hepatitis B and C in the dawn of the third millenium].
    Adler M; Bourgeois N
    Rev Med Brux; 2001 Jun; 22(3):141-51. PubMed ID: 11488081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New epidemiological data on liver oncogenesis.
    Kountouras J; Lygidakis NJ
    Hepatogastroenterology; 2000; 47(33):855-61. PubMed ID: 10919047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral hepatitis and hepatocellular carcinoma: update in 2012.
    Kudo M
    Dig Dis; 2012; 30(6):539-40. PubMed ID: 23258091
    [No Abstract]   [Full Text] [Related]  

  • 19. [New insights from the German guideline "hepatocellular carcinoma"].
    Plentz RR; Malek NP;
    Dtsch Med Wochenschr; 2014 Dec; 139(49):2529-31. PubMed ID: 25423464
    [No Abstract]   [Full Text] [Related]  

  • 20. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma.
    Branda M; Wands JR
    Hepatology; 2006 May; 43(5):891-902. PubMed ID: 16628664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.